BPA Call HT001415A0010-0008
Award Date 10/6/15
Potential Completion Date 10/5/16
Potential Value $2.3M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $2,800,000.00 Blanket Purchase Agreement (BPA) Call contract is for the provision of reagents and peripheral consumables. The contract is not designated as a set-aside. Roche Diagnostics holds multiple Indefinite Delivery Vehicles (IDVs) and BPAs with federal agencies such as...
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, with a ceiling value of $302,000.00, is a Blanket Purchase Agreement (BPA) Call placed by the Defense Health Agency (DHA) for the procurement of REAGENTS AND CONSUMABLES. This BPA is part of a larger Indefinite Delivery Contract vehicle held by Roche Diagnostics to provide chemistry reagents...
- This federal contract award is a Blanket Purchase Agreement (BPA) against the VA Schedule #V797P-7347A for reagents and consumables. The prime contractor is Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award was made by the Defense Health Agency, an agency within the U.S. Department of Defense, and has a ceiling value of $311,035.97...
- This federal contract award is a Blanket Purchase Agreement (BPA) against the Department of Veterans Affairs (VA) Schedule #V797P-7347A for reagents and consumables. The contract has a ceiling value of $346,018.42 and was awarded to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics and associated products and services. The contract is a Firm Fixed Price arrangement and provides the Defense Health Agency (DHA) with the ability to purchase critical care...
- The Defense Health Agency has awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, a global manufacturer of in vitro diagnostic products and laboratory equipment, for the provision of reagents and consumables. This contract is a child award under the VA Schedule V797P-7347A and carries a ceiling value of $288,642.16 under firm fixed-price terms. The award was made on April 30, 2025, with an ultimate completion date of May 2, 2025, and no set-aside designation was...
- The U.S. Defense Health Agency awarded Roche Diagnostics Corporation a Blanket Purchase Agreement (BPA) call valued at $2,515,000.00 for the provision of reagents and consumables. This is not a set-aside contract. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies, including the Department of Veterans Affairs, Department of...
- Roche Diagnostics Corporation has been awarded a $225,869.71 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide reagents and consumables. The contract has a period of performance through February 17, 2023. As the prime contractor, Roche Diagnostics will deliver the requested laboratory supplies to support the Defense Health Agency's medical research and healthcare programs. No subcontractors or set-aside designations were identified for this...
- This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $3,330,384.44, is for the provision of reagents and peripherals with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating Roche Diagnostics competed openly in the...
- This is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation for reagents and consumables for medical laboratory testing. The BPA is against VA Schedule Contract #V797P-7347A, which enables DHA to efficiently acquire Roche's diagnostic technologies through pre-negotiated pricing and terms. The contract has a ceiling value of $354,198.51 and a period of performance through May 2, 2025. No set-aside designation was used for this award....
- This is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents and consumables. The BPA, valued at $344,741.86, was established against Roche's existing General Services Administration (GSA) Schedule contract for critical laboratory analyzers and supplies. The BPA allows DHA facilities to purchase essential medical equipment and consumables through pre-negotiated pricing and terms with...